Ultherapy vs Thermage in Myeongdong: 16 Questions for Your Consultation

Ultherapy vs Thermage in Myeongdong is not a choice with one universal winner. Ultherapy uses microfocused ultrasound, while Thermage FLX uses radiofrequency (RF). A useful consultation identifies the actual device, treatment area, evidence, safety considerations, and travel plan for the care being discussed. This guide is general education, not medical advice or a diagnosis.

Key Takeaways

• Ultherapy and Thermage are different energy-based modalities; an exact model and treatment area matter more than a broad “lifting” label.
• A small randomized face-and-neck comparison found no statistically significant difference between the studied modalities at six months; it does not establish a universal best option.
• U.S. labeling and FDA clearance do not establish Korean authorization, local availability, or individual suitability.
• Discuss relevant history, implants, prior procedures, follow-up, and travel timing before deciding.

Start with the device category, then verify the model

In U.S. labeling, the Ulthera System uses focused ultrasound and can use imaging to visualize tissue depth for skin contact and treatment planning (FDA 510(k) K243035; Ulthera System IFU). Thermage CPT/FLX is described by its manufacturer as a non-invasive RF system (Thermage HCP safety information).

For an Ultherapy vs Thermage Myeongdong consultation, ask the clinic to identify the actual system or generation, applicable tip or transducer, and proposed area. The Ultherapy consultation page and Thermage consultation page can help you prepare. Brand names, translated marketing terms, and social-media descriptions are not device verification.

The cited FDA and manufacturer materials are U.S. materials. They do not show whether a device is authorized for a particular use in Korea. Ask what local authorization and labeling apply to the proposed plan.

Ask what concern and treatment area are actually being discussed

Start with the concern, not an expectation that another person’s result can be reproduced. Ask which area is being assessed, what change is realistic to discuss, and why a modality is being proposed rather than an alternative—or waiting.

The American Academy of Dermatology places ultrasound and RF among non-invasive skin-tightening categories, with generally modest, gradual changes rather than the result of a surgical lift (AAD: Many ways to firm sagging skin). That is context, not a forecast for you. Response can vary by person, area, baseline laxity, prior procedures, and protocol.

If another energy-based option is raised, ask the same model-and-purpose questions. The full treatment overview can help identify separately named options; it is not a menu of interchangeable procedures.

What does comparison evidence say—and not say?

In one randomized, split-face, evaluator-blind study, 20 people with mild-to-moderate face and upper-neck laxity received monopolar RF on one side and microfocused ultrasound with visualization on the other. At six months, both sides improved on the study’s laxity scale, with no statistically significant difference between sides in investigator measures, patient satisfaction, or adverse events (Alhaddad et al., 2019).

That is a reason not to treat the two names as a simple league table. It was also a small, defined study, not a guarantee for a different person, device generation, treatment area, or protocol.

A 2023 systematic review found microfocused ultrasound appeared effective for mild-to-moderate facial laxity, but noted that studies commonly excluded more marked laxity, enrolled mostly adult women, and needed more objective outcome measures (Contini et al., 2023). Ask what evidence relates to the proposed area and how closely it resembles your situation.

Put safety screening before a brand preference

The exact device labeling is one reason clinical history matters. U.S. Ulthera labeling lists open wounds or lesions, severe or cystic acne in the treatment area, and active or metallic implants in the treatment area as contraindications. Listed potential effects include temporary redness, swelling, discomfort, bruising, altered sensation or transient nerve effects; burns and scarring can occur with incorrect technique (Ulthera System IFU).

For Thermage CPT/FLX, the U.S. manufacturer lists implantable electrical devices as a contraindication and identifies several situations that have not been studied, including use over skin fillers and use in pregnancy or breastfeeding. Possible reactions listed include discomfort, edema, erythema or blanching, bruising, burns, scarring, altered sensation, nodules, and pigment change (Thermage HCP safety information). These lists are not a self-screening tool and do not predict an individual reaction.

RF microneedling is separate from non-invasive Thermage. The FDA’s 2025 safety communication concerns RF devices with microneedles that penetrate the skin, so it should not be presented as a warning about Thermage (FDA RF microneedling safety communication). If RF microneedling or a separately named RF option such as XERF is raised, ask for its exact device, purpose, and risk discussion.

Share relevant health history, medicines, allergies, active skin concerns, implants, and prior procedures. If you have unexpected or concerning symptoms after any procedure, seek prompt in-person medical assessment rather than relying on an online diagnosis.

Plan the Myeongdong visit around follow-up, not convenience alone

Daybeau Clinic Myeongdong Signature is at B1, 84 Namdaemun-ro, Jung-gu, Seoul, approximately one minute from Euljiro 1-ga Station Exit 6. Convenience does not replace a plan for questions, recovery considerations, or access to care after leaving Seoul.

Before making a request, note arrival and departure dates, flights, and time-sensitive events. Ask what follow-up could be relevant and how communication would work once you are no longer in Korea. A form submission is a consultation request, not appointment confirmation.

The CDC recommends that travelers plan how to obtain health care abroad, review insurance, and carry medication and health information (CDC: South Korea Traveler View). Those are travel-health precautions, not aesthetic-treatment instructions. For clinic-specific preparation, see International Patients.

Take these questions to the consultation

Use plain language and ask for answers tied to the actual plan:

1. What concern and treatment area are we discussing?
2. What exact device model, applicator, tip, or transducer is proposed?
3. Is the proposed use locally authorized for this area?
4. Why this modality rather than an alternative or waiting?
5. What evidence is most relevant to this device, area, and goal?
6. What can this approach reasonably not change?
7. What short-term effects and uncommon serious complications matter?
8. Which medicines, implants, fillers, or prior procedures could change the discussion?
9. Are there active skin issues or other reasons to postpone or avoid it?
10. How will the area and device settings be selected?
11. What aftercare and warning signs are relevant?
12. What happens if I have a concern after leaving Seoul?
13. How does my departure date affect practical follow-up?
14. Can I have the device and care details in writing before deciding?
15. Is it reasonable to take time to consider the information?
16. If I am uncertain, what information should I clarify before making a decision?

A thoughtful answer can include uncertainty or a decision not to proceed. To begin the conversation, send a consultation request with your dates and questions. This article cannot determine treatment suitability or replace an individual clinical assessment.

Frequently asked questions

Is Ultherapy ultrasound or RF?

Ultherapy is associated with microfocused ultrasound. U.S. FDA and manufacturer documents for the named Ulthera System describe focused ultrasound and, with the applicable transducer, ultrasound visualization. Thermage is a separate non-invasive RF system. Confirm the actual device proposed.

Is Thermage an RF microneedling procedure?

No. Thermage CPT/FLX is described as non-invasive RF. FDA’s 2025 communication concerns RF microneedling devices that use needles to penetrate the skin, so that warning should not be generalized to Thermage. A clinic should still explain the risks for any device it proposes.

Which is better: Ultherapy or Thermage?

Neither is universally better. A small six-month split-face trial in people with mild-to-moderate face and upper-neck laxity found no statistically significant difference between the studied RF and microfocused-ultrasound sides. It does not decide suitability for another person, area, or device configuration.

Can I have Ultherapy or Thermage if I have an implanted device or filler?

Do not self-clear. U.S. Ulthera labeling lists certain active or metallic implants in the treatment area as contraindications. U.S. Thermage labeling lists implantable electrical devices as contraindications and says use over skin fillers has not been studied. Tell the clinician about all implants, fillers, and prior procedures.

How should I plan if I am in Seoul briefly?

Share your Seoul dates, departure, and time-sensitive events before deciding. Ask how follow-up would work if you leave Korea and make a general plan for access to care while traveling. A consultation request does not confirm an appointment or treatment.